Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT04797949

Withdrawn

Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia

Medication Adherence | Preeclampsia
NCT04997382

Completed

Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC (CLASSIC5)

Non-small Cell Lung Cancer
NCT06635317

Completed

Efficacy of Aspirin in Preventing Venous Thromboembolism

Venous Thromboembolism (VTE) | Total Joint Arthroplasty | Total Hip Arthroplasty (THA)
NCT01306045

Completed

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Carcinoma, Non-Small-Cell Lung | Carcinoma, Small Cell Lung | Carcinoma, Thymic
NCT06153784

Completed

Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients

Thalassemia, Beta
NCT01164228

Completed

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Kidney Cancer
NCT04861948

Terminated

IBI188 Combination Therapy in Solid Tumors

Osteosarcoma | Lung Adenocarcinoma | Solid Tumors
NCT00560495

Withdrawn

Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Lung Cancer
NCT03651102

Completed

Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia (Thal-Thalido)

Thalassemia
NCT05169801

Completed

To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC

Non-small Cell Lung Cancer(NSCLC)
NCT02807441

Withdrawn

Perioperative Bleeding and Aspirin Use in Spine Surgery (ASA)

Hemorrhage | Thrombosis
NCT00025285

Completed

Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer
NCT03362788

Completed

The Greek AntiPlatElet Atrial Fibrillation Registry. (GRAPE-AF)

Coronary Artery Disease | Atrial Fibrillation
NCT01922154

Completed

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Glaucoma, Neovascular
NCT02697916

Completed

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term (ADAPTABLE)

Atherosclerotic Cardiovascular Disease
NCT02354612

No longer available

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Solid Tumors
NCT04535804

Unknown

Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery

Adenomyosis of Uterus
NCT02121990

Completed

Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer
NCT04517526

Unknown

Efficacy and Safety of Platinum-based Chemotherapy + Bevacizumab + Durvalumab, and Salvage SBRT for IV Non-Small Cell Lung Cancer Patients With EGFR Mutations After Failure of First Line Osimertinib: A Multicenter, Prospective, Phase II Clinical Study

Lung Cancer Stage IV，EGFR-mutant，TKI，PD-L1，SBRT
NCT02825719

Terminated

Ulipristal Use in Chinese Population

Fibroid
NCT03450317

Unknown

Influence of Aspirin on Human Gut Microbiota Composition and Metabolome

Aspirin | Microbiota
NCT00761891

Completed

Validation of an Assay to Measure Cyclooxygenase-1 Activity

Healthy
NCT02350543

Terminated

Peri-operative Aspirin Continuation Versus Discontinuation

Urinary Bladder Neoplasms | Hematuria
NCT02671461

Completed

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

Thrombosis
NCT00748163

Withdrawn

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Lung Cancer
NCT03405974

Unknown

Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip

Osteonecrosis of Femoral Head | Osteonecrosis; Aseptic, Idiopathic
NCT00400803

Completed

Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
NCT00178464

Completed

Aspirin Prophylaxis in Sickle Cell Disease (START)

Sickle Cell Disease
NCT02687867

Completed

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist (DABI-F)

Atrial Fibrillation
NCT02690155

Completed

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA (RIVA-F)

Atrial Fibrillation
NCT00351039

Terminated

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer
NCT01504867

Completed

LIPS-A: Lung Injury Prevention Study With Aspirin

Acute Respiratory Distress Syndrome
NCT00110448

Completed

Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

Coronary Disease | Arteriosclerosis | Diabetes Mellitus, Type 2
NCT02359643

Unknown

Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease

Kawasaki Disease
NCT00469976

Withdrawn

Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer

Lung Cancer
NCT02253004

Completed

Induction of Migraine Aura With Cilostazol

Stroke | Migraine With Aura
NCT01674647

Completed

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion (X-VERT)

Atrial Fibrillation
NCT01409564

Completed

Cilostazol Augmentation Study in Dementia

Alzheimer's Dementia
NCT01465256

Unknown

Postpolypectomy Bleeding in Patients With Antiplatelet Therapy

Bleeding Complication During Colon Polypectomy
NCT00387920

Completed

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific | Central Nervous System Metastases | Childhood Central Nervous System Germ Cell Tumor | Childhood Central Nervous System Choriocarcinoma | Childhood Central Nervous System Germinoma | Childhood Central Nervous System Mixed Germ Cell Tumor | Childhood Central Nervous System Teratoma | Childhood Central Nervous System Yolk Sac Tumor | Recurrent Childhood Central Nervous System Embryonal Tumor | Childhood Central Nervous System Embryonal Tumor
NCT01069328

Completed

Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung | Lung Cancer
NCT01188824

Completed

The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)

Ischemic Stroke
NCT00462852

Completed

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer | Thromboembolism
NCT00939991

Completed

Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas

Glioblastoma | Brain Tumor
NCT00784446

Completed

First-line Therapy of Stage IV Colorectal Cancer

Stage IV Colorectal Cancer
NCT00126633

Completed

Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer
NCT00224679

Terminated

APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence

Colon Adenomas
NCT00039468

Completed

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

Brain and Central Nervous System Tumors
NCT00222677

Unknown

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Atherosclerosis | Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis
NCT01244100

Completed

Food-Effect Pharmacokinetic Study of PL2200

Healthy

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations